MedPageToday
MedPage Today) — MADRID — Beta-blockers may be relegated to a smaller role for secondary prevention after myocardial infarction (MI) in contemporary practice, based on the arrival of three new trials from Europe.
Putting aside their known…
Read More
More Definitive Evidence Carves Out LVEF Zone for Beta-Blockers After MI
Georgianna Mischke
03:21
MedPage Today) — MADRID — Beta-blockers may be relegated to a smaller role for secondary prevention after myocardial infarction (MI) in contemporary practice, based on the arrival of three new trials from Europe. Putting aside their known…
